Loading organizations...
Loading organizations...
Drug discovery company developing stable, peptidase-resistant peptides.
Lanthio Pharma has raised $11.1M across 2 funding rounds.
Lanthio Pharma has raised $11.1M in total across 2 funding rounds.
Lanthio Pharma has raised $11.1M in total across 2 funding rounds.
Lanthio Pharma's investors include RVO, BioGeneration Ventures, INKEF Capital, Hanzepoort, MorphoSys.
Lanthio Pharma has raised $11.1M across 2 funding rounds. Most recently, it raised $4.9M Debt in May 2014.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 21, 2014 | $4.9M Debt | RVO | |
| Nov 28, 2012 | $6.2M Series A | BioGeneration Ventures, INKEF Capital | Hanzepoort, MorphoSys |